We have an updated report [Version - 2026] available. Kindly sign up to get the sample of the report.

ATAXIA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2021 - 2028)

Ataxia Market, by Treatment Type (Pharmacotherapy (Levodopa, Pramipexole, Desvenlafaxine, Venlafaxine, and Others (Acetazolamide, Scopolamine, Buspirone, Tizanidine, etc.)), Physical Therapy, Speech Therapy, and Others (Adaptive Devices and Occupational Therapy)), by Disease Type (Friedreich\'s Ataxia, Ataxia-telangiectasia, Spinocerebellar Ataxias, Episodic Ataxia, and Others (Multiple System Atrophy (MSA))), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In: 25 Oct, 2021
Code: CMI4714
Page number: 150
Formats: Excel and PDF
Industry: Pharmaceutical

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Treatment Type
  - Market Snippet, By Disease Type
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Pipeline Analysis
- PEST Analysis
- Regulatory Scenario
- Market Trends
- Key Highlights
- Reimbursement Scenario
- Mergers & Acquisitions
Global Ataxia Market, By Treatment Type, 2017 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2018 – 2028
  - Segment Trends
- Pharmacotherapy
  - Levodopa
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  - Pramipexole
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  - Desvenlafaxine
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  - Venlafaxine
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  - Others (Acetazolamide, Scopolamine, Buspirone, Tizanidine, etc.)
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  - Physical Therapy
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  - Speech Therapy
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  - Others (Adaptive Devices and Occupational Therapy)
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Global Ataxia Market, By Disease Type, 2017 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2018 – 2028
  - Segment Trends
- Friedreich's Ataxia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Ataxia-telangiectasia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Spinocerebellar Ataxias
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Episodic Ataxia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others (Multiple System Atrophy (MSA))
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Global Ataxia Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2018 – 2028
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Global Ataxia Market, By Region, 2017 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, By Region, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, For Regions, 2018–2028
- North America
  - Market Size and Forecast, By Treatment Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Disease Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
    - U.S.
    - Canada
- Latin America
  - Market Size and Forecast, By Treatment Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Disease Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Market Size and Forecast, By Treatment Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Disease Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Market Size and Forecast, By Treatment Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Disease Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Market Size and Forecast, By Treatment Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Disease Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Market Size and Forecast, By Treatment Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Disease Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Region/Country, 2017 – 2028, (US$ Mn)
    - South Africa
    - Central Africa
    - North Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
  - Pfizer Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - CRISPR Therapeutics
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Acorda Therapeutics
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Capsida Biotherapeutics Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Larimar Therapeutics, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Healx
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Intellia Therapeutics, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Editas Medicine
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - bluebird bio, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Sanofi
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Merck & Co., Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - H. Lundbeck A/S
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Cellectis SA
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Bio-Techne
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - GlaxoSmithKline plc
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Allergan
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
- Analyst Views
Section
- References
- Research Methodology
- About us and Sales Contact

*Browse 33 market data tables and 25 figures on "Ataxia Market” - Global forecast to 2028

Instant Download - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now